• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Poultry Vaccines Market

    ID: MRFR/HC/6046-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Poultry Vaccines Market Research Report By Type (Live Attentuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation), By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Poultry Vaccines Market Infographic
    Purchase Options

    Poultry Vaccines Market Summary

    As per Market Research Future analysis, the Poultry Vaccines Market was valued at 2.05 USD Billion in 2024 and is projected to grow to 3.97 USD Billion by 2035, reflecting a CAGR of 6.18% from 2025 to 2035. The market is driven by rising poultry product consumption, technological advancements in vaccine development, and increasing outbreaks of poultry diseases. Key players are focusing on innovative vaccine solutions to enhance poultry health and productivity.

    Key Market Trends & Highlights

    The Global Poultry Vaccines Market is experiencing significant transformations driven by various factors.

    • Rising demand for poultry products is projected to increase by 1.5% annually, necessitating effective vaccination.
    • Technological advancements, including recombinant vaccines, could enhance vaccination efficiency rates by up to 30%.
    • Poultry diseases outbreaks have increased by approximately 20% over the past five years, emphasizing the need for effective vaccines.
    • Live Attenuated Vaccines are expected to grow from 2.05 USD Billion in 2024 to 3.97 USD Billion by 2035.

    Market Size & Forecast

    2024 Market Size USD 2.05 Billion
    2035 Market Size USD 3.97 Billion
    CAGR (2025-2035) 6.18%

    Major Players

    Bioniche Animal Health, Vetoquinol, Elanco, Ceva Santé Animale, Indian Immunologicals, Merck Animal Health, Phibro Animal Health, MVP Labs, AgriLabs, Boehringer Ingelheim, Valley Veterinary, Merial, Zoetis, HIPRA

    Poultry Vaccines Market Trends

    The Global Poultry Vaccines Market is undergoing notable changes due to a variety of forces. One of the major drivers of the market is the increasing consumption of poultry products, which has spurred investment in vaccine development and implementation. There is heightened concern over food safety and public health, which increases the need for proper vaccination measures to manage poultry disease outbreaks. This fact is supported by many governments appreciating the role of vaccinations in maintaining the stability of food production and controlling viral infections that threaten poultry farming.

    Under the global scope, emerging markets such as recombinant vaccines with improved efficacy and safety representation offer new unexplored possibilities.

    Furthermore, the increase in the number of small and medium-sized poultry farms creates a new market opportunity for cost-effective and high-quality vaccination products. New digital technologies are also opening up possibilities for optimizing vaccination procedures as well as farm management systems. Recent patterns show that more attention is directed towards region-specific vaccine creations, with more emphases placed on adaptable and precise formulations for prevalent localized diseases. There is a growing emphasis on reinforcing preventative measures in vaccination, which iswhy emerging markets are focusing on building their veterinary infrastructure.

    There is a growing partnership cooperation between many of the stakeholders such as government bodies, agri-businesses, and private enterprises to accelerate research and innovations in vaccine creation and their distribution. These various aspects underline the need for proactive health management and poultry vaccines globally while simultaneously achieving sustainable food productivity and livestock welfare.

     

    The ongoing advancements in vaccine technology are poised to enhance the efficacy and safety of poultry vaccines, thereby potentially transforming disease management in the poultry industry.

    U.S. Department of Agriculture (USDA)

    Poultry Vaccines Market Drivers

    Advancements in Vaccine Technology

    Innovations in vaccine technology significantly influence the Global Poultry Vaccines Market Industry. The development of recombinant vaccines, vector-based vaccines, and DNA vaccines enhances the efficacy and safety of poultry immunization. These advancements not only improve disease control but also reduce the reliance on antibiotics, aligning with global health initiatives. The introduction of more effective vaccines is likely to contribute to the market's growth, as poultry producers seek to optimize flock health and productivity. As a result, the market is expected to grow at a CAGR of 4.34% from 2025 to 2035.

    Emerging Markets and Globalization

    Emerging markets present substantial opportunities for the Global Poultry Vaccines Market Industry. As countries in Asia, Africa, and Latin America experience economic growth, the demand for poultry products increases. Globalization facilitates the exchange of knowledge and technology, enabling these regions to adopt advanced vaccination practices. The expansion of poultry farming in these markets necessitates effective vaccination strategies to prevent disease outbreaks. Consequently, the market is poised for growth as producers in emerging economies seek to enhance productivity and meet rising consumer demand.

    Rising Demand for Poultry Products

    The Global Poultry Vaccines Market Industry experiences a surge in demand for poultry products, driven by increasing population and changing dietary preferences. As consumers shift towards protein-rich diets, the need for healthy and disease-free poultry becomes paramount. This trend is reflected in the projected market value of 4.7 USD Billion in 2024, with expectations to reach 7.5 USD Billion by 2035. The growing awareness of food safety and quality further emphasizes the necessity for effective vaccination programs, thereby propelling the demand for poultry vaccines globally.

    Market Trends and Growth Projections

    The Global Poultry Vaccines Market Industry is characterized by various trends and growth projections. The market is expected to reach a value of 4.7 USD Billion in 2024, with a projected increase to 7.5 USD Billion by 2035. This growth is underpinned by a CAGR of 4.34% from 2025 to 2035. Factors such as technological advancements, rising demand for poultry products, and government regulations contribute to this positive outlook. The market's trajectory suggests a robust future, driven by the ongoing need for effective disease prevention in poultry farming.

    Increasing Awareness of Animal Health

    The growing awareness of animal health among poultry producers significantly impacts the Global Poultry Vaccines Market Industry. Producers are increasingly recognizing the importance of vaccination in maintaining flock health and productivity. Educational programs and outreach initiatives by veterinary associations and agricultural organizations promote best practices in poultry management. This heightened awareness leads to increased adoption of vaccination protocols, ultimately driving market growth. As producers prioritize animal welfare and biosecurity measures, the demand for effective vaccines is likely to rise, further supporting the industry's expansion.

    Government Initiatives and Regulations

    Government initiatives and regulations play a crucial role in shaping the Global Poultry Vaccines Market Industry. Many countries implement stringent vaccination programs to combat poultry diseases, which can have devastating economic impacts. Regulatory bodies often mandate vaccination against specific diseases, thereby driving the demand for vaccines. For instance, the World Organisation for Animal Health promotes vaccination as a key strategy for disease prevention. Such initiatives not only enhance animal health but also ensure food security, thereby fostering a favorable environment for the poultry vaccine market.

    Market Segment Insights

    Poultry Vaccines Market Type Insights

    The Global Poultry Vaccines Market, a vital segment of the veterinary pharmaceuticals industry, is fundamentally categorized by Type, comprising Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, and DNA Vaccines. In 2024, the market is expected to see notable valuations, reflecting the progress and increased demand for poultry health products. The Live Attenuated Vaccines category holds a majority stake within the market, valued at 1.6 USD Billion, and is projected to grow to 2.5 USD Billion by 2035, driven by their effectiveness in eliciting robust immune responses in poultry.

    These types of vaccines have been widely utilized due to their efficacy and cost-effectiveness, making them a preferred choice among poultry producers worldwide. Following closely, Inactivated Vaccines are expected to reach a valuation of 1.4 USD Billion in 2024 and grow to 2.2 USD Billion by 2035, providing substantial protection against specific diseases.

    Their safety profile and reliability in disease prevention serve as primary factors contributing to their significant uptake. The Subunit Vaccines segment, which is valued at 1.2 USD Billion in 2024 with a growth forecast to 2.0 USD Billion by 2035, is pivotal as it offers tailored immune protection without the risk of virulence associated with live vaccines.This segment is gaining traction due to the increasing awareness of biosecurity measures in poultry farming. Additionally, DNA Vaccines are estimated to be valued at 0.5 USD Billion in 2024, with an expected increase to 0.8 USD Billion by 2035.

    Poultry Vaccines Market Species Insights

    The Global Poultry Vaccines Market, valued at 4.7 billion USD in 2024, plays a crucial role in enhancing animal health and productivity across various poultry species. The market encompasses several key species such as Broilers, Layers, Turkeys, and others. Broilers are significant contributors to the market, owing to their high demand for meat production, which makes them a primary focus for vaccination efforts aimed at reducing diseases. Layers also represent a substantial segment, driven by the growing need for egg production and associated health measures.

    Turkeys, though smaller in number compared to the aforementioned categories, require vaccines to ensure optimal growth and meat quality, reflecting a niche yet essential market segment. The Others category captures various poultry types, further diversifying the Global Poultry Vaccines Market segmentation and providing opportunities for specialized vaccine development. With increasing global meat consumption, the demand for effective H1N1 Vaccination solutions continues to grow, highlighting the importance of these species in maintaining poultry health and productivity while addressing market trends and consumer needs within the Global Poultry Vaccines Market industry.

    Poultry Vaccines Market Administration Route Insights

    The Administration Route segment of the Global Poultry Vaccines Market poised for considerable growth, contributing to a projected market valuation of 4.7 billion USD in 2024. This segment encompasses various methods such as Intramuscular, Subcutaneous, Oral, and Inhalation, each playing a vital role in vaccine delivery to poultry. The Intramuscular route is often favored for its efficiency and rapid immune response, while the Oral route is appreciated for its ease of administration and reduced stress on animals. Subcutaneous vaccination, recognized for its less invasive approach, remains significant, particularly in large-scale poultry operations.

    The Inhalation method, though less common, offers advantages in terms of mass vaccination and reducing the risk of disease transmission. Market trends indicate a shift towards more innovative delivery systems that improve vaccination efficacy and animal welfare. With increasing poultry production worldwide and escalating demand for meat products, the Global Poultry Vaccines Market is expected to flourish, driven by these Administration Route methods. Challenges such as managing vaccine storage and maintaining biosecurity will need addressing, yet opportunities for advancements remain plentiful within this segment.

    Poultry Vaccines Market Disease Targeted Insights

    The Global Poultry Vaccines Market focuses significantly on the Disease Targeted segment, representing a crucial aspect of poultry health management worldwide. In 2024, this particular segment plays a key role in shaping the overall market, valued at 4.7 billion USD. The segment includes crucial diseases such as Newcastle Disease, Infectious Bursal Disease, Avian Influenza, and Marek's Disease, each playing a vital role in poultry production and health. Newcastle Disease vaccines are pivotal as they maintain flock health and reduce mortality rates, thus ensuring reliable poultry production.

    Infectious Bursal Disease, recognized for its impact on immunity in younger chicks, highlights the need for effective vaccination strategies to safeguard their health. Avian Influenza remains a global threat due to its potential for zoonotic transmission and has prompted governments to invest in vaccine development to prevent outbreaks. Marek's Disease vaccines are essential in controlling the spread of this virus which can lead to significant losses in commercial poultry.

    The market growth is driven by the rising demand for poultry meat and eggs alongside growing awareness about animal health, enhanced biosecurity practices, and advancements in vaccine technology within the Global Poultry Vaccines Market industry.The segmentation of disease-targeted vaccines reflects a proactive approach towards managing specific animal diseases that directly influence poultry productivity and biosecurity measures globally.

    Get more detailed insights about Poultry Vaccines Market Research Report – Forecast till 2035

    Key Companies in the Poultry Vaccines Market market include

    Industry Developments

    Recent developments in the Global Poultry Vaccines Market highlight a surge in demand driven by an increase in poultry farming and a growing focus on food safety and biosecurity measures. Companies such as Elanco and Zoetis have been innovating in vaccine technology, aiming to improve efficacy against various avian diseases. Notably, in October 2023, Merck Animal Health announced a strategic partnership with an agricultural research firm to enhance vaccine development processes.

    In addition, Bioniche Animal Health launched a new vaccine line aimed at combating infectious bronchitis in poultry, demonstrating ongoing advancements in the sector. In terms of mergers and acquisitions, Ceva Santé Animale’s acquisition of a prominent vaccine manufacturing company was finalized in September 2023, expanding its product portfolio significantly. Furthermore, there have been noticeable growth trends, with the market valuation projected to rise substantially, reflecting increasing investments in Research and Development (RD) by multiple key players.

    Over the last few years, the Global Poultry Vaccines Market has also faced challenges such as supply chain disruptions caused by the COVID-19 pandemic, which have underscored the need for robust vaccine strategies and collaborations among industry leaders.

    Future Outlook

    Poultry Vaccines Market Future Outlook

    The Global Poultry Vaccines Market is projected to grow at a 6.18% CAGR from 2025 to 2035, driven by increasing poultry production and rising awareness of animal health.

    New opportunities lie in:

    • Develop innovative vaccine delivery systems to enhance efficacy and reduce costs. Expand product lines to include vaccines for emerging poultry diseases. Leverage digital platforms for targeted marketing and distribution strategies.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements in vaccine technology and heightened demand.

    Market Segmentation

    Poultry Vaccines Market Type Outlook

    • Live Attentuated Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines

    Poultry Vaccines Market Species Outlook

    • Broilers
    • Layers
    • Turkeys
    • Others

    Poultry Vaccines Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Poultry Vaccines Market Disease Targeted Outlook

    • Newcastle Disease
    • Infectious Bursal Disease
    • Avian Influenza
    • Marek's Disease

    Poultry Vaccines Market Administration Route Outlook

    • Intramuscular
    • Subcutaneous
    • Oral
    • Inhalation

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 20234.5(USD Billion)
    MARKET SIZE 20242.05 (USD Billion)
    MARKET SIZE 20357.5 (USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)6.18% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2023
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDBioniche Animal Health, Vetoquinol, Elanco, Ceva Santé Animale, Indian Immunologicals, Merck Animal Health, Phibro Animal Health, MVP Labs, AgriLabs, Boehringer Ingelheim, Valley Veterinary, Merial, Zoetis, HIPRA
    SEGMENTS COVEREDType, Species, Administration Route, Disease Targeted, Regional
    KEY MARKET OPPORTUNITIESIncreasing demand for poultry products, Advancements in vaccine technology, Growing awareness of animal health, Expansion in emerging markets, Rising prevalence of poultry diseases
    KEY MARKET DYNAMICSincreasing disease outbreaks , growing poultry consumption , rising awareness of vaccination , advancements in vaccine technology , government regulations and policies
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 20242.05
    Market Size 20252.18
    Market Size 20353.97
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected market size of the Global Poultry Vaccines Market in 2024?

    The Global Poultry Vaccines Market is expected to be valued at 4.7 USD Billion in 2024.

    What is the anticipated market size of the Global Poultry Vaccines Market by 2035?

    By 2035, the market is projected to reach a valuation of 7.5 USD Billion.

    What is the expected compound annual growth rate (CAGR) for the Global Poultry Vaccines Market from 2025 to 2035?

    The market is expected to exhibit a CAGR of 4.34% during the forecast period from 2025 to 2035.

    Which region is expected to dominate the Global Poultry Vaccines Market by 2035?

    North America is anticipated to hold a significant market share, with a projected value of 2.1 USD Billion by 2035.

    What will be the market size of Live Attenuated Vaccines segment in 2035?

    The Live Attenuated Vaccines segment is forecasted to reach a market size of 2.5 USD Billion by 2035.

    What are the projected figures for Inactivated Vaccines by 2035?

    The Inactivated Vaccines segment is expected to be valued at 2.2 USD Billion in 2035.

    Who are the key players in the Global Poultry Vaccines Market?

    Major players include Elanco, Merck Animal Health, Zoetis, and Boehringer Ingelheim among others.

    What is the expected market size for Subunit Vaccines in 2035?

    The Subunit Vaccines market segment is projected to be valued at 2.0 USD Billion in 2035.

    How will the MEA region perform in the poultry vaccines market by 2035?

    The MEA region is expected to see growth, with a market value of 0.4 USD Billion in 2035.

    What will be the size of the DNA Vaccines segment by 2035?

    The DNA Vaccines segment is projected to reach a market size of 0.8 USD Billion in 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials